The Asia-Pacific cancer diagnostics landscape is undergoing significant transformation. According to UnivDatos, the market is projected to grow at a CAGR of approximately 8%, reaching an estimated value of USD ~XX billion by 2032. As the region faces increasing cancer incidences and ongoing improvements in healthcare infrastructure, early detection and accurate diagnosis are becoming central to...